A sample report on

Global Patient
Support Programs
Market Analysis
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2021 – 2030F)

www.insights10.com
3 AUDIOBOOK COLLECTIONS

6 BOOK COLLECTIONS
This report presents a strategic analysis of the Global Patient Support
Program market and a forecast for its development in the medium and
long term. It provides a comprehensive overview of the market value,
dynamics, segmentation, characteristics, main players, trends and insights,
growth and demand drivers, challenges & future outlook, etc. This is one of
the most comprehensive reports about the Global Patient Support Program
market, and offers unmatched value, accuracy, and expert insights
 • Introduction
• Market Overview
• Growth Drivers & Restraints

Table of • Market Segmentation

• Major Market Share

Contents • Competitive Landscape

• Pharma Companies Sponsored PSPs
• Healthcare Policies & Regulatory Framework
• Factors Driving Future Growth
• Conclusion
Table of Contents
1. Introduction…………………………………………………………………………………….………………………………..…………..7
1.1 Need for Patient Services
1.2 Patient support programs: What do they offer?
1.3 Various Patient Services
1.3.1 Caregiver Access
1.3.2 Healthcare Financing
1.3.3 Self Care/Compliance
1.4 Strong Desire for Support Services from Pharma Manufacturers
2. Global Patient Support Program Market Overview………………..……..…………………………………...................................15
2.1 Market size and forecast
3. Market Growth Drivers and Restraints….………………………………………………………………….…………….…………….17
3.1 Market Growth Drivers
3.1.1 Greater focus on Value and Outcomes
3.1.2 Growth in availability of Health Data
3.1.3 Shift from Reactive to Proactive Consumer
3.1.4 Rise of Personalized Medicine
3.2 Market Restraints

4 A Sample Report on Global Patient Support Program Market I Confidential

Table of Contents (continued)
3.2.1 Siloed and Uncoordinated communications
3.2.2 Lack of Data Governance
3.2.3 Challenge of Program Management
3.2.4 Cost Ambiguity
4. Market Segmentation……………………………………………………………….…………………..…………………..………….….24
4.1 By Caregiver Access
4.2 By Healthcare Financing
5. Major Products Market Share………………………..…………………………………………………………………..…………....…28
5.1 Market Analysis, Insights and Forecast - By Revenue
6. Competitive Landscape……………………………………………………..……………………...…………..…................................30
6.1 Major companies for global market
7. Pharma companies sponsored PSP Programs…………………………………………………………...………………..…….......32
7.1 Connect360 (AstraZeneca)
7.2 Amgen Assist 360 (Amgen)
7.3 BMS Access Support (Bristol Myers Squibb)
7.4 Lilly Cares (Eli Lilly)

5 A Sample Report on Global Patient Support Program Market I Confidential

Table of Contents (continued)
8. Healthcare Policies and Regulatory Landscape…………………………………………………….……………………..………....37
8.1 Regulatory framework of global patient support program market
9. Factors Driving Future Growth………………………………………………………………………………………………..………....39
9.1 Recent developments in patient support program
10. Strategic Recommendation……………………..…………..………………………………….……………………………………….41

6 A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis

1. Introduction
1.1 Need for Patient Services

People experience various difficulties around starting their medications and continuing to take them as prescribed, leading
to suboptimal behaviors that result in non-adherence

▪ Medication adherence is one of healthcare’s greatest and most costly challenges

▪ Non-adherence is estimated to cause approximately xx deaths in the US annually, costing the US health care
system up to $xx Bn/ year
▪ It is a nuanced and multi-factorial challenge, and patients’ needs while on treatment are highly differentiated

More serious the health condition of a patient, the more

Many patients want to receive support via phone. However, various digital channels like

8 A Sample Report on Global Patient Support Program Market I Confidential

 1.2 Patient Support Programs: What do they offer?

Patient Support Programs (PSPs)

Patient Access Programs Patient Adherence Programs Convenience Programs

Financial
Named Patient Patient Education Other Support
Assistance Loyalty Programs
Programs (NPP) Programs Programs
Programs

9 A Sample Report on Global Patient Support Program Market I Confidential

1.3 Various Patient Services

Caregiver Access Healthcare Financing Self Care/ Compliance

Virtual Care/ Benefit Coverage Patient Education/

Telehealth (BI/PA/Appeal) discovery

Remote Monitoring Co-pay assistance Medication delivery /

support

10 A Sample Report on Global Patient Support Program Market I Confidential

1.3.1 Caregiver Access – (1/2)

Virtual Care/
Platform enabling remote delivery of healthcare services
Telehealth

Companies in the space

Remote patient monitoring enables monitoring of patients outside conventional clinical settings
Remote Monitoring
thereby increasing access to care and reducing healthcare delivery costs

Companies in the space

Companies in the space

11 A Sample Report on Global Patient Support Program Market I Confidential

1.3.2 Healthcare Financing – (1/3)

Electronic Prior ePA is the electronic transmission of information between the prescriber, and payer to determine
Authorization (ePA) whether or not the PA is granted

Companies in the space

Real Time Benefits Providers need visibility into patient benefits to determine patient’s needs. RTBV technologies
Verification integrate this information into provider workflows to improve care planning

Companies in the space

Companies in the space

12 A Sample Report on Global Patient Support Program Market I Confidential

1.3.3 Self Care / Compliance

Patient Education Tools and platform that enables healthcare professionals and physicians to impart information and
knowledge to patients thereby altering their health behaviors and improving health outcomes

Companies in the space

Services enabling timely delivery of prescriptions at patients doorstep/ convenient location to

Medication Delivery
drive long term adherence through convenience

Companies in the space

Companies in the space

13 A Sample Report on Global Patient Support Program Market I Confidential

 1.4 Strong Desire for Support Services from Pharma Manufacturers
Survey of more than 1,000 patients with chronic / complex conditions was conducted to evaluate the patient experience on
therapy: commonly encountered challenges related to access and adherence, support used, preferred, and expectations from
the manufacturer of the medications

xx% of respondents believe that pharma companies

xx% respondents needed financial and copay support should offer patient support services

xx% respondents wanted services for frequent xx% of those with complex or chronic conditions say
medication reminders that they would opt in for patient support services

xx% people wanted companion to talk to about their

xx% of cancer and xx% of lupus patients agreed to
medication and emotional concerns while dealing with
opting patient support services
disease and treatment
xx% were aware of the patient support services that are
xx% said increased communications from a physician currently offered by drug manufacturers, despite its high
or nurse would be most beneficial demand

xx% said calls/visits from a nurse who is an expert in xx% actually reported utilization of pharma-provided
the medication the patient is on would be most helpful services

14 A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis

2. Overview
 2.1 Market Size and Forecast

Global Patient Support Program Market Size $Bn Key Analysis

Patients believe pharmaceutical companies have a

xx% responsibility

Patients are aware of the services that pharmaceutical

xx% companies

xx% Pharma companies are raising their investment in

5.1

xx% Healthcare professionals are very aware of

Patients believe that pharma companies should be

xx% working more closely with
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F

16 A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis

3. Growth Drivers & Restraints

 Market growth drivers and restraints

Greater Focus on Value Growth in Availability of Shift from Reactive Rise of Personalized
Market Drivers

and Outcomes Health Data to Proactive Consumer Medicine

Impact
Market Restraints

Impact

Siloed and Uncoordinated Lack of Data Governance Challenge of Program Cost Ambiguity
communications Measurement

18 A Sample Report on Global Patient Support Program Market I Confidential

3.1 Market growth drivers

3.1.1 Greater Focus on Value and Outcomes

▪ Life sciences organizations are under pressure to justify their pricing and to demonstrate that their drugs can
improve treatment outcomes

19 A Sample Report on Global Patient Support Program Market I Confidential

3.1 Market growth drivers (continued)

3.1.2 Growth in Availability of Health Data

▪ Sources like electronic medical records, claims and billing information, big data from wearables or social media
helps companies understand the quality, efficiency and safety of their treatments

20 A Sample Report on Global Patient Support Program Market I Confidential

3.1 Market growth drivers (continued)

3.1.3 Shift from Reactive to Proactive Consumer

▪ Patients today take a more active role in managing their own health

21 A Sample Report on Global Patient Support Program Market I Confidential

3.1 Market growth drivers (continued)

3.1.4 Rise of Personalized Medicine

▪ With growth of specialty drugs and personalized therapies, demand for individualized treatments is increasing

22 A Sample Report on Global Patient Support Program Market I Confidential

3.2 Market restraints

3.2.1 Siloed and Uncoordinated

3.2.2 Lack of Data Governance
communications

▪ Patient services programs typically are executed ▪ Patient services data is often unstructured and
by multiple departments for multiple brands lacking when it comes to data governance and
utilizing both internal teams and external stewardship…..
partners leading to…..

3.2.3 Challenge of Program Measurement 3.2.4 Cost Ambiguity

▪ Measuring patient services program ▪ Generally, cost prediction is done at the

effectiveness is often unstructured and lacks aggregate level for multiple programs and in
clear success criteria, manufacturers will annual buckets, and there is no clear…..
utilize…..

23 A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis

4. Market Segmentation
Global Patient Support Program Market Segmentation

Patient Support Program Market Segmentation

Caregiver Access Healthcare Financing

Virtual Care/ Telehealth Benefit Coverage (BI/PA/Appeal)

Remote Monitoring Co-pay assistance

Healthcare at Home Alternative Coverage / PAPs

Patient Transportation Reimbursement Support

Health Coaching

25 A Sample Report on Global Patient Support Program Market I Confidential

 4.1 Market Segmentation: By Caregiver Access

Patient Support Program Market Share by Caregiver Access Key Insights

(2021)

▪ Remote patient monitoring enables monitoring of patients

outside conventional clinical settings thereby increasing
access to care and reducing healthcare delivery costs
▪ Home healthcare is a supportive care provided by medical
professionals at patient’s home for the purpose of
promoting, maintaining or restoring health or maximizing
the level of independence while minimizing the effects of
disability and illness

Virtual Care/ Remote Healthcare at Patient Health

Telehealth Monitoring Home Transportation Coaching

26 A Sample Report on Global Patient Support Program Market I Confidential

 4.2 Market Segmentation: By Healthcare Financing

Patient Support Program Market Share by Healthcare Financing Key Insights

(2021)

▪ Electronic Prior Authorization (ePA)- it is the electronic

transmission of information between the prescriber, and
payer to determine whether or not the PA is granted
▪ Reimbursement Support - Services remove barriers to
successful payment of claims and provide a resource for
patients with coverage-related questions

Benefit Coverage Co-pay Alternative Reimbursement

(BI/PA/Appeal) Assistance Coverage / PAPs Support

27 A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis

5. Major Market Share

 5.1 Major Patient Support Program Market Share

Key Insights

▪ From the pharmaceutical company’s perspective, PSPs contribute to better patient outcomes overall, and as the industry shifts
more toward outcomes-based payment models, enhancing actual patient outcomes will be a crucial success element
▪ A strong patient support program will influence the approval of treatments and market authorizations and will boost patient
enrollment

29 A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis

6. Competitive Landscape
6.1 Major players revenue (current and forecast)

Major Market Revenue of Patient Support Services Key Insights

Companies ($Bn)

SAMPLE

AstraZeneca Amgen (Assist Bristol Myers Eli Lilly (Lilly

(Access 360) 360) Squibb (Access Cares)
Support)

Revenue share used for PSP Other revenue

31 A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis

7. Pharma companies sponsored PSP Programs

 7.1 Connect360 (AstraZeneca)

Respective PSP Overview Company at a Glance

▪ The AstraZeneca Patient Support Programs help patients Company Name: AstraZeneca
navigate the complexities of reimbursement and provide
support during the journey of their treatment
▪ Connect360, AstraZeneca Oncology patient support programs Year of Establishment: 1999
are some of the PSPs going on currently

Headquarter: Cambridge, US

Revenue: $37.4 Bn (2021)

Website: www.astrazeneca.com

33 A Sample Report on Global Patient Support Program Market I Confidential

 7.2 Amgen Assist 360 (Amgen)

Respective PSP Overview Company at a Glance

▪ In 2019, the Amgen Safety Net Foundation provided nearly Company Name: Amgen
$1.5 billion worth of our medicines to qualified uninsured or
underinsured patients in the U.S. at no cost -and Early $7
billion of our medicines since 2008
Year of Establishment: 1980
▪ Amgen Assist 360 provides financial support options for any
insurance type and referrals to resources for day-to-day living

Headquarter: Cambridge, US

Revenue: $26 Bn (2021)

Website: www.amgen.com

34 A Sample Report on Global Patient Support Program Market I Confidential

 7.3 BMS Access Support (Bristol Myers Squibb)

Respective PSP Overview Company at a Glance

▪ Bristol Myers Squibb is committed to helping appropriate Company Name: Bristol Myers Squibb
patients get access to our medications by providing access
and reimbursement support services`
▪ BMS Access Support® is focused on your patients’ access Year of Establishment: 1887
needs benefits Review, prior authorization, and appeals
assistance, easy-to-initiate co-pay assistance process and
information on financial support and support from Patient
Access Specialists, assigned by region, and local Access and Headquarter: New York, US
Reimbursement Managers

Revenue: $46.4 Bn (2021)

Website: www.bms.com

35 A Sample Report on Global Patient Support Program Market I Confidential

 7.4 Lilly Cares (Eli Lilly)

Respective PSP Overview Company at a Glance

▪ Lilly Cares Foundation, Inc. (Lilly Cares) is a nonprofit Company Name: Eli Lilly
charitable organization that provides prescribed Lilly
medications for free for up to 12 months to qualifying U.S.
patients
Year of Establishment: 1876
▪ Over the past 20 years, Lilly Cares has helped more than one
million patients with financial need receive medicines donated
by Lilly
Headquarter: Indiana, US

Revenue: $28.3 Bn (2021)

Website: www.lilly.com

36 A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis

8. Healthcare Policy and Regulatory Landscape

8.1 Regulatory framework of global patient support program market

▪ Many countries, regions, and industry groups have local regulations that directly address (and often restrict) these
programs. For example, Canada, the UK and Australia have industry codes specifically addressing PSPs and, in
some cases, patient safety and data requirements or interactions with healthcare professionals (HCPs) and patients
in connection with PSPs
▪ Reimbursement of patient support program is done by various ways like bridging drugs (temporary or limited supply
of drug directly to a patient, provider, or institution), financial assistance (Payment on part of the drug cost; Payment
may be based on applicant’s; income and family size; Payment may be given to someone with or without coverage in
place) and compassionate drugs (temporary or long-term supply of drug to person in unique clinical situation)

38 A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis

9. Future Development Growth

9.1 Recent developments in patient support program

▪ AI, machine learning and natural language processing tools can identify both clinical and socioeconomic data points
to ensure patient support teams are spending time with the right patients, particularly with those who may be closer
to non-adherence

▪ Pharma manufacturers often use training materials to create awareness for these programs, a channel growing in
popularity is actively participating in the patient journey — more specifically, connectivity with electronic health
records (EHRs) systems to augment education. These integrations builds improved awareness for providers,
growing program adoption

40 A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis

10. Conclusion
 Strategic Recommendations

Growing Technology
Advancements
With the emerging
technology and the
transformation from…..

Emerging Initiative
Ease in regulations by the Support for the HCPs
government and Patient support programs are
collaborations between….. also assisting HCPs to
deliver…..

3
2 4
Strong Demand
Advancement in healthcare
With the implementation of
delivery
government norms
PSPs would enhance the
towards…..
way healthcare was delivered
1 5 to the patient earlier, with…..

42 A Sample Report on Global Patient Support Program Market I Confidential

Methodology & Scope
 Research methodology

▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ In our report we have assigned weights to the US specific parameters and quantified the market impacts. Which similarly, could be
useful in identifying the global scenario
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ The currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion

44 A Sample Report on Global Patient Support Program Market I Confidential

Analysis methodology

Our Analysis Methodology involves three critical stages:

Market Data Analysis Interpretation and

Data Collection
& Statistical Model Presentation

Analysis &
Market Trends
Interpretation
Secondary
Research
Market Sizing & Insights
Analysis
Primary
Research
Data Triangulation & Presentation &
Validation Reporting

45 A Sample Report on Global Patient Support Program Market I Confidential

Data triangulation and data validation

Top Down Approach

Final
Final Market size break up to
Market
rest of segmentation
Size

Validation from Arriving at market size

Primary Interview of each segment

Summarization of revenue
generated from companies Validation from
to arrive at total market size Primary Interview

Revenue generated by products & Final

services offered by companies Summary

Bottom Up Approach

46 A Sample Report on Global Patient Support Program Market I Confidential

Key benefits for stakeholders from this report

The study provides an in-depth analysis of the Global Patient Support Program market with current trends and future
estimations to elucidate the imminent investment pockets

Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables

Comprehensive analysis of factors that drive and restrict the market growth is provided

Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities

Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally

Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

47 A Sample Report on Global Patient Support Program Market I Confidential

 Time Frame Report Attribute Details

Quantitative Units Revenue in USD Million/Billion (Mn/Bn)

Base Year for
2021
Estimation Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Report Coverage
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities

Report Customization (5 working days) with

purchase. We will provide you with data that is
Customized Report
currently not a part of our scope as a part of
2022- Forecast customization
2030 Period
Pricing and purchase Avail customized purchase options to meet
options your exact research needs
What kind of Data is Presented
in this Report?
This report presents data, which is:

Reliable Expert-verified Real Comprehensive Easy to read

The report is prepared The data is prepared by Allowing you to Covers everything you You do not have to be a
using a proven a team of highly qualified confidently make would need to know market expert to
methodology and & experienced research smarter business about the market understand what really is
insightful research analysts & vetted by our and strategic including market size, happening on the market
local associates decisions competitive analysis & and how it works
much more

www.insights10.com
About
Lifesciences Market
Research Reports you
can trust
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs

www.insights10.com
Get Insights to take
informed Business
Decisions
Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses

www.insights10.com
 Market Research Reports
across various domains of healthcare

Pharmaceuticals Digital Medical Healthcare OTC & Clinical

(Diseases & Drugs) Health Devices Services Nutraceuticals Trials
 Market Research Reports 1 6 Full-Time Engagement

Customized Reports 2 7 Conference Coverage

Our
Primary Research 3 8 Competitive Intelligence
Services
Strategic Research Projects 4 9 Regulatory Compliance

Database Services 5 10 Report Subscription Services

Our Research Process

01 02 03 04 05

Identification of Market Collection of Collaboration Verification &

Data Dynamics Data of Data Analysis

www.insights10.com
 Statistical Databases

Company Websites/Annual Reports

Data
Sources Trade Publications

We have access to multiple highly Online Databases

reliable free and subscription data
sources. We have many years of
experience to understand which Published Research Reports
sources are more dependable for what
and which to prefer for the reliable and
latest information. Whitepapers

Press Releases of Key Market Players

www.insights10.com
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.

Our team has

conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Research Projects Done

 Project Leadership Team

Dr. Purav Gandhi Mukesh Nayak Ritu Baliya Dhruv Joshi

Founder & CEO Head - Marketing Engagement Manager Consultant
Purav is a physician and an Mukesh is an engineering graduate Ritu has over 6 years of experience in Dhruv Joshi is an engineer and has done
entrepreneur with 12+ years of with an MBA in Marketing. He is a strategy building, market assessments, Masters in Hospital Administration with
experience in Healthcare & Life seasoned healthcare market market sizing, and RWE for global MNC over 4 years of experience in the
Sciences industry spanning across research & marketing professional healthcare & biopharma clients across healthcare and life science industry. He
strategy, market access, health with a progressive experience of over diff. markets (America, Europe, Africa, has gained proficiency in market
informatics and RWE, digital health, 20 years in Life Sciences, Pharma APAC and Middle East). Her areas of research, market assessment, and
analytics and data science. Purav and Medical Device sectors . With an expertise include: Indentifying emerging developing insights from it. He has
studied medicine from Gujarat in-depth understanding of primary trends in life sciences industry, worked on various consulting projects
University and also completed his MBA research, he has conducted Competitor landscape assessment, across different geographies including
from IIM-Kozhikode. Purav started his hundreds of interviews of various Disease opportunity assessments etc. Asia, Europe, US, MENA. He has been
career with Deloitte working on strategy stakeholders in pharma & healthcare She is a pro in secondary and primary aligned in working for sector reports of
consulting engagements and also co- & completed several research research with a deep domain expertise various geographies along with market
founded ConvergeHealth by Deloitte. projects across life sciences industry. in healthcare sector. sizing and forecasting.
7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below

… and many more

We would be happy to help.

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
Whatsapp: (+91) 931 639 7935
3 AUDIOBOOK COLLECTIONS

6 BOOK COLLECTIONS